U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C3H4O2
Molecular Weight 72.0627
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROPIOLACTONE

SMILES

O=C1CCO1

InChI

InChIKey=VEZXCJBBBCKRPI-UHFFFAOYSA-N
InChI=1S/C3H4O2/c4-3-1-2-5-3/h1-2H2

HIDE SMILES / InChI

Molecular Formula C3H4O2
Molecular Weight 72.0627
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Propiolactone (or beta-propiolactone) is a disinfectant used in vapor form to sterilize vaccines, grafts, blood plasma, surgical instruments. It has been used against bacteria, fungi, and virus. Propiolactone was first commercially available in the United States in 1958 but then was withdrawn because it was discovered that compound was a human carcinogen. The results have shown the generation of tumors in several tissues and from different administration routes. Propiolactone is a direct-acting alkylating agent that reacts with polynucleotides and DNA, mainly at N7 of guanine and N1 of adenine, to form carboxyethyl derivatives.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
1989
beta-Propiolactone.
2002
Platelet adhesion onto segmented polyurethane surfaces modified by carboxybetaine.
2003
Development of a non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine.
2003 Jan
The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
2004
Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
2004 Dec
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.
2004 Dec 10
Vero-cell rabies vaccine produced using serum-free medium.
2004 Dec 9
In vitro inactivation of the rabies virus by ascorbic acid.
2004 Jan
Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice.
2004 Jun
[Direct identification of Ophiogon japonicus (Thunb.)Ker-Gawl. from its confusable varieties by second derivative FTIR spectroscopy combined with statistics].
2004 Sep
Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies.
2005 Apr 15
SARS vaccine protective in mice.
2005 Aug
Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines.
2005 Aug 15
Ru-catalyzed alkene-alkyne coupling. Total synthesis of amphidinolide P.
2005 Dec 21
Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols.
2005 Jan
Reactivity of lactones and GHB formation.
2005 Jan 21
A kinetic approach to the alkylating potential of carcinogenic lactones.
2005 Jul
[Conditions for SARS-CoV cultivation and inactivation].
2005 Jun
Profile of animal bite cases in Pune.
2005 Mar
[Development of purified HFRS bivalent vaccine].
2005 Mar
Modulation of macrophage functions by sheeppox virus provides clues to understand interaction of the virus with host immune system.
2005 Mar 22
Role of activation function domain-1, DNA binding, and coactivator GRIP1 in the expression of partial agonist activity of glucocorticoid receptor-antagonist complexes.
2005 Mar 8
Dengue type 3 virus, Saint Martin, 2003-2004.
2005 May
Ophiopojaponin D, a new phenylpropanoid glycoside from Ophiopogon japonicus Ker-Gawl.
2005 Nov
Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia.
2006 Dec
Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine.
2006 Feb 13
Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
2006 Jan
Structures of heterogeneous proton-bond dimers with a high dipole moment monomer: covalent vs electrostatic interactions.
2006 May 11
Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.
2007
Frequencies of mutagen-induced coincident mitotic recombination at unlinked loci in Saccharomyces cerevisiae.
2007 Mar 1
Enzymatic synthesis of poly(hydroxyalkanoates) in ionic liquids.
2007 Nov 1
Efficiency of Matricaria chamomilla CH12 and number of doses of rabies vaccine on the humoral immune response in cattle.
2008 Dec
Development of stable influenza vaccine powder formulations: challenges and possibilities.
2008 Jun
Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs).
2008 Oct 2
Serological response in cattle immunized with inactivated oil and Algel adjuvant vaccines against infectious bovine rhinotracheitis.
2009 Apr
Matrix photochemistry, photoelectron spectroscopy, solid-phase structure, and ring strain energy of beta-propiothiolactone.
2009 Apr 16
Pandemic influenza vaccines - the challenges.
2009 Dec
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo.
2009 Jan
Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
2009 Mar 26
From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?
2009 Nov 24
Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex.
2009 Sep 29
Safety and efficacy of an inactivated Carbopol-adjuvanted goose haemorrhagic polyomavirus vaccine for domestic geese.
2010 Apr
Use of the hemagglutinating virus of Japan (HVJ) envelope as a versatile delivery system for nucleic acids and proteins to leukocytes in vitro.
2010 Apr
Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
2010 Aug 25
Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria.
2010 Jul 27
Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine.
2010 Jun
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
2010 Jun 22
GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis.
2010 Nov 3
Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine.
2010 Oct
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:25:36 GMT 2025
Edited
by admin
on Mon Mar 31 18:25:36 GMT 2025
Record UNII
6RC3ZT4HB0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PROPIOLACTONE
HSDB   INN   MART.   ORANGE BOOK   USAN  
INN   USAN  
Official Name English
?-Propiolactone
MI  
Preferred Name English
BETAPRONE
Brand Name English
NSC-21626
Code English
BETA-PROPIOLACTONE
Common Name English
BETA-PROPIOLACTONE [IARC]
Common Name English
.BETA.-PROPIOLACTONE [MI]
Common Name English
PROPIOLACTONE [USAN]
Common Name English
propiolactone [INN]
Common Name English
PROPIOLACTONE [ORANGE BOOK]
Common Name English
PROPIOLACTONE [HSDB]
Common Name English
PROPIOLACTONE [MART.]
Common Name English
2-OXETANONE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C45187
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
IARC beta-Propiolactone
NCI_THESAURUS C606
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
Code System Code Type Description
WIKIPEDIA
BETA-PROPIOLACTONE
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
NSC
21626
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
EPA CompTox
DTXSID8021197
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
DRUG CENTRAL
3495
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
MESH
D011420
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
RXCUI
1311565
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY RxNorm
FDA UNII
6RC3ZT4HB0
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
CHEBI
49073
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
EVMPD
SUB10109MIG
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
HSDB
811
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
INN
1749
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
MERCK INDEX
m9204
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY Merck Index
SMS_ID
100000081358
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
PUBCHEM
2365
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
DRUG BANK
DB09348
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-340-1
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
ChEMBL
CHEMBL1200627
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
CAS
57-57-8
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
NCI_THESAURUS
C44339
Created by admin on Mon Mar 31 18:25:36 GMT 2025 , Edited by admin on Mon Mar 31 18:25:36 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY